Cerebrovascular reactivity and dynamic autoregulation in ischaemic subcortical white matter disease

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 80, Issue 10, 2009, Pages 1093-1098

  Birns, Jonathan ^a,b   Jarosz, J ^c   Markus, H S ^d   Kalra, L ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c KING S COLLEGE HOSPITAL   (United Kingdom)

^d ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CARBON DIOXIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ORAL ANTIDIABETIC AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; AUTOREGULATION; BLOOD PRESSURE MONITORING; BLOOD PRESSURE VARIABILITY; BLOOD VESSEL REACTIVITY; BRAIN INFARCTION; BRAIN PERFUSION; BRAIN SIZE; CEREBROVASCULAR DYNAMIC AUTOREGULATION; DISEASE DURATION; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; HYPERCAPNIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; LEUKOARAIOSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; WHITE MATTER;

AGED; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CARBON DIOXIDE; CEREBROVASCULAR CIRCULATION; COHORT STUDIES; FEMALE; HOMEOSTASIS; HUMANS; LEUKOARAIOSIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL; VASODILATION;

EID: 70349662032     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2009.174607     Document Type: Article

References (39)

1. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-1041 (Pubitemid 32925123)
2. Isaka Y, Okamoto M, Ashia K, et al. Decreased cerebrovascular dilatory capacity in subjects with asymptomatic periventricular hyperintensities. Stroke 1994;25:375-381 (Pubitemid 24047263)
3. Kuwabara Y, Ichiya Y, Sasaki M, et al. Cerebral blood flow and vascular response to hypercapnia in hypertensive patients with leukoaraiosis. Ann Nucl Med 1996;10:293-298 (Pubitemid 26327234)
4. Bakker SL, de Leeuw FE, de Groot, et al. Cerebral vasomotor reactivity and cerebral white matter lesions in the elderly. Neurology 1999;52:578-583 (Pubitemid 29075607)
5. 2-induced cerebral vasomotor response in normal individuals and patients with internal carotid artery occlusions. Stroke 1988;19:963-969
6. Dawson SL, Blake MJ, Panerai RB, et al. Dynamic but not static cerebral autoregulation is impaired in acute ischaemic stroke. Cerebrovasc Dis 2000;10:126-132
7. Markus H, Cullinane M. Severely impaired cerebrovascular reactivity predicts stroke and TIA risk in patients with carotid artery stenosis and occlusion. Brain 2001;124:457-467 (Pubitemid 32221313)
8. Molina C, Sabin JA, Montaner J, et al. Impaired cerebrovascular reactivity as a risk marker for first-ever lacunar infarction: A case-control study. Stroke 1999;30:2296-2301 (Pubitemid 29517725)
9. Cupini LM, Diomedi M, Placidi F, et al. Cerebrovascular reactivity and subcortical infarctions. Arch Neurol 2001;58:577-581
10. Marinoni M, Ginanneschi A, Ancona AL, et al. Orthostatic transcranial Doppler variations in patients with leukoaraisois. Neurology 1991;41(Suppl 1):123.
11. Inzitari D, Ginanneschi A, Ancona AL, et al. Evaluation of cerebral autoregulation in patients with leucoaraiosis. Ital J Neurol Sci 1991;(Suppl 5):22.
12. Matsushita K, Kuriyama Y, Nagatsuka K, et al. Periventricular white matter lucency and cerebral blood flow autoregulation in hypertensive patients. Hypertension 1994;23:565-568 (Pubitemid 24129348)
13. Kario K, Shimada K, Pickering TG. Abnormal nocturnal blood pressure falls in elderly hypertension: clinical significance and determinants. J Cardiovasc Pharmacol 2003;41(Suppl 1):S61-6. (Pubitemid 36015035)
14. Siennicki-Lantz A, Reinprecht F, Axelsson J, et al. Cerebral perfusion in the elderly with nocturnal blood pressure fall. Eur J Neurol 2007;14:715-720 (Pubitemid 47012175)
15. Tiecks FP, Lam AP, Aaslid R, et al. Comparison of static and dynamic autoregulatory mechanisms. Stroke 1995;26:1014-1019
16. van Boxtel MPJ, Henskens LHG, Kroon AA, et al. Ambulatory blood pressure, asymptomatic cerebrovascular damage and cognitive function in essential hypertension. J Hum Hypertens 2006;20:5-13.
17. Kario K, Matsuo T, Kobayashi H, et al. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Hypertension 1996;27:130-135
18. Birns J, Morris R, Jarosz J, et al. Ethnic differences in the cerebrovascular impact of hypertension. Cerebrovasc Dis 2008;25:408-416 (Pubitemid 351754635)
19. Newell DW, Aaslid R, Lam A, et al. Comparison of flow and velocity during dynamic autoregulation testing in humans. Stroke 1994;25:793-797 (Pubitemid 24111325)
20. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;363:307-310 (Pubitemid 16134762)
21. White RP, Markus HS. Impaired dynamic cerebral autoregulation in carotid artery stenosis. Stroke 1997;28:1340-1344 (Pubitemid 27300667)
22. Mahony PJ, Panerai RB, Deverson ST, et al. Assessment of the thigh cuff technique for measurement of dynamic cerebral autoregulation. Stroke 2000;31:476-480
23. White RP, Vallance P, Markus HS. Effect of inhibition of nitric oxide synthase on dynamic cerebral autoregulation in humans. Clin Sci (Lond) 2000;99:555-560 (Pubitemid 32014563)
24. Kario K, Pickering TG. Blood pressure variability in elderly patients. Lancet 2000;355:1645-1646 (Pubitemid 30240521)
25. Meguro K, Hatazawa J, Yamaguchi T, et al. Cerebral circulation and oxygen metabolism associated with subclinical periventricular hyperintensity as shown by magnetic resonance imaging. Ann Neurol 1990;28:378-383 (Pubitemid 20292625)
26. Yamori Y, Horie R. Developmental course of hypertension and regional cerebral blood flow in stroke-prone spontaneously hypertensive rats. Stroke 1977;8:456-461 (Pubitemid 8148566)
27. Birns J, Kalra L. Pathogenesis of cerebral small vessel disease. In: Roux OC, ed. Brain hypoxia ischemia research progress. New York: Nova Science Publishers, 2008.
28. 2 responsiveness of the brain. Am J Physiol Heart Circ Physiol 2006;291:H2018.
29. Lundar T, Lindegaard KF, Froysaker T, et al. Dissociation between cerebral autoregulation and carbon dioxide reactivity during nonpulsatile cardiopulmonary bypass. Ann Thorac Surg 1985;40:582-587 (Pubitemid 16186103)
30. Walters M, Muir S, Shah I, et al. Effect of perindopril on cerebral vasomotor reactivity in patients with lacunar infarction. Stroke 2004;35:1899-1902 (Pubitemid 38971872)
31. Sayk F, Becker C, Teckentrup C, et al. To dip or not to dip: on the physiology of blood pressure decrease during nocturnal sleep in healthy humans. Hypertension 2007;49:1070-1076 (Pubitemid 351664316)
32. Aaslid R, Lindegaard KF, Sorteberg W, et al. Cerebral autorgeulation dynamics in humans. Stroke 1989;20:45-52.
33. Panerai RB. Assessment of cerebral pressure autoregulation in humans - a review of measurement methods. Physiol Meas 1998;19:305-338
34. Huber P, Handa J. Effect of contrast material, hypercapnia, hyperventilation, hypertonic glucose and papaverine on the diameter of cerebral arteries. Invest Radiol 1967;2:17-32.
35. Ramsay SC, Murphy K, Shea SA, et al. Changes in global cerebral blood flow in humans: effect on regional cerebral blood flow during a neural activation task. J Physiol 1993;471:521-534 (Pubitemid 23345593)
36. Panerai RB, Evans DH, Naylor AR. Influence of arterial blood pressure on cerebrovascular reactivity. Stroke 199;30:1293-1295
37. Cencetti S, Fattorini L, Bacalli S, et al. Potential pitfalls in cerebral autoregulation testing. Cerebrovasc Dis 1997;7:312.
38. Panerai RB, Rennie JM, Kelsall AWR, et al. Frequency-domain analysis of cerebral autoregulation from spontaneous fluctuations in arterial blood pressure. Med Biol Eng Comput 1998;36:315-322 (Pubitemid 28258609)
39. Moorhouse P, Rockwood K. Vascular cognitive impairment: current concepts and clinical developments. Lancet Neurol 2008;7:246-255 (Pubitemid 351215983)